PreComb
Founded 2018 · 12 employees on LinkedIn · 2 known investors
PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.
Investors · 2
Frequently asked questions
- What does PreComb do?
- PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.
- Who are PreComb's investors?
- PreComb's investors include LongeVC, Kinled Holding.